---
title: 'Mannes M, Dopler A, Zolk O, etÂ al. Complement inhibition at the level of C3
  or C5: mechanistic reasons for ongoing terminal pathway activity. Blood. 2021;137(4):443-455'
date: '2024-04-25'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38662389/?utm_source=curl&utm_medium=rss&utm_campaign=journals&utm_content=7603509&fc=None&ff=20240426181351&v=2.18.0.post9+e462414
source: Blood
description: No ...
disable_comments: true
---
No ...